VERTEX PHARMACEUTICALS INC / MA (VRTX)
Clinical trial NCT06185764 updates: 1. completion date: 2026-12-22 → 2027-02-02 2. primary completion date: 2026-12-22 → 2027-02-02 3. enrollment: 44 → 52 participants
Clinical trial NCT06185764 updates: 1. completion date: 2026-12-22 → 2027-02-02 2. primary completion date: 2026-12-22 → 2027-02-02 3. enrollment: 44 → 52 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical